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Several species of cyanobacteria has been recognized for its therapeutic value that can be used for 
treatment of malnutrition, cancer and viral infection. Many natural occurring cyanobacteria are known to 
produce toxins, for example, species of the genera Microcystis, Nodularia, Nostoc, Anabaena, 
Aphanizomenon, Cylindrospermopsis, and Planktothrix (Oscillatoria). Cyanotoxins are classified 
according to their mode of action in vertebrates as hepatotoxins, neurotoxins, cytotoxins, 
dermatotoxins, and irritants. Microcystin is a hepatotoxin which commonly found in Microcystis and it 
was found to be produced by other genera, including Anabaena, Nostoc, Nodularia, and Planktothrix. In 
the present study cyanobacteria strain isolated from Egyptian soil was purified, characterized and 
identified as Nostoc sp. and named Nostoc EGY. PCR-based techniques targeting the toxin biosynthesis 
genes were used verifying absence of toxic genes in the newly purified cyanobacteria. Cell lysate was 
prepared from the purified strain; the efficacy of this lysate to prevent hepatitis C virus (HCV) replication 
in vitro was proved qualitatively and quantitatively. Lysate prepared from isolated cyanobacteria after 10 
and 25 days of cultivation was able to prevent replication of in vitro cultivated HCV. 
 





Cyanobacteria as one of the oldest fossils on earth, more 
than 3.5 billion years, they are aquatic and photosynthetic 
unicellular microorganisms (Botos and Wlodawer, 2003; 
Laura G. Barrientos, 2008). Cyanobacteria are growing in 
a wide range of habitats and were named for the blue-
green pigment, phycocyanin. Usually, they grow in large 
colonies include unicellular, colonial, and filamentous 
forms and can be considered as one of the largest and 
most important groups of bacteria on earth. 
Cyanobacteria that lack toxins are widely used as food 
supplement as well as in complementary and alternative 
medicine (Gao, 1998; Liu Chenglong, 2009). Several 
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Species of cyanobacteria has been recognized for its 
therapeutic value that can be used for treatment of 
malnutrition, cancer and viral infection due to presence of 
medicinally active component that varied according to 
cyanobacteria species (Helle et al., 2006). For example 
CV-N is an 11 kDa protein of known three-dimensional 
structure produced mainly by Nostoc strains of 
cyanobacteria, where CV-N blocks HIV infection by 
binding to the surface envelope glycoprotein, gp120. 
Further study of the mechanism of CV-N/gp120 
interaction revealed that CV-N bound to high-mannose 
oligosaccharides on gp120, specifically, oligomannose-8 
(Man-8) and oligomannose-9 (Man-9).  Moreover CV-N 
was proved to be active against certain other viruses, 
such as the Ebola virus and HCV, whose envelope 
proteins possess similar oligosaccharide structures. 
Therefore in HCV infection, CV-N as mannose binding 
protein has the ability to bind to hepatitis C (HCV) viral 
particle where HCV envelop as mannose rich protein and 
prevent its entry to the host cells, consequently prevent 
viral replication. Also the same action by CV-N is 
applicable with other viruses with envelope similar to that 
of HCV viral particles (Buffa et al., 2009; Liu et al., 2009; 
O'Keefe et al., 2003; Tsai et al., 2004). 
Many natural occurring cyanobacteria are known to 
produce toxins, for example, species of the genera 
Microcystis, Nodularia, Nostoc, Anabaena, 
Aphanizomenon, Cylindrospermopsis, and Planktothrix 
(Oscillatoria) (Haider et al., 2003; O.M. Skulberge et al., 
1993; Rao et al., 2002) Cyanotoxins are classified 
according to their mode of action in vertebrates as 
hepatotoxins, neurotoxins, cytotoxins, dermatotoxins, and 
irritants (Carmichael et al., 2001). Microcystin is a 
hepatotoxin which commonly found in Microcystis and it 
was found to be produced by other genera, including 
Anabaena, Nostoc, Nodularia, and Planktothrix. It is a 
cyclic heptapeptide produced non-ribosomally by a 
multifunctional enzyme complex consisting of peptide 
synthetase (PS)-polyketide synthase (PKS) modules and 
tailoring enzymes, they act by inhibiting protein 
phosphatase 1 and 2 (PP1 and PP2A) (Goldberg et al., 
1995; MacKintosh et al., 1990). 
PCR-based techniques were developed for targeting 
the toxin biosynthesis genes and they have become 
popular methods for detecting and quantifying toxic 
species due to their specificity, sensitivity, and speed 
(Dittmann and Wiegand, 2006; Furukawa et al., 2006; 
Ouellette et al., 2006). Characterization of the genes 
responsible for hepatotoxin biosynthesis has made it 
possible to design general PCR primers that target the 
aminotransferase (AMT) domains of the mycE and ndaF 
genes (Jungblut et al., 2006) allowing detection of 
microcystin and nodularin-producing cyanobacteria. 
 
 
MATERIALS AND METHODS 
 
Isolation and cultivation of blue green algae 
 
Blue green algae had been isolated from soil of Rice field in river 




Nile Delta. The isolation of a single algal unit into medium for 
growth is required to establish a clonal, unialgal culture by streak 
plating on BG12 or BG13 media. This method serves to isolate an 
algal unit less than 10 µm diameter (Ferris and Hirsch, 1991). 
Plates were incubated at 30°C for 4 to 8 days under suitable growth 
conditions (light cycle). Using stereomicroscope the desired 
colonies that are free of other microorganism were selected for 
further isolation. The purity of the selected colonies was determined 
by examining samples from each selected colony using a fine wire 
needle and examined with a high power objective of the compound 
microscope. The pure colonies were transferred into liquid or agar 
media (BG12 or BG13) (Ferris and Hirsch, 1991). 
The purified colonies of blue green algae were cultivated in a 
BG12 sterile modified medium (Elango, 2008); the algae were 
grown in a batch culture at 30°C illuminated by cool white lamp. 
The cells were allowed to grow for 10 days to density equal to 32 
mg/ml and were harvested by cooling centrifugation; the pellets 
were stored at -20°C. 
 
 
Light and scanning electron microscopy  
 
The fresh unialgal culture from the isolated cyanobacteria was 
examined with an Olympus BX 40 Phase contrast light microscope. 
A part from the fresh culture was dried; the specimen was sputter-
coated with gold and examined with a Joel scanning electron 
microscope (SEM, JSM-6360; Joel, Japan) at 10 kV. The 
morphological identification of cyanobacteria was done according to 
Komárek and Anagnostidis (Komárek, 1998; 2005). 
 
 
Identification and amplification of 16S rDNA and ITS-23S rDNA 
genes 
 
DNA was isolated from the samples as described by Tillett and 
Neilan (2000) and quantified using UV spectrophotometer 
(NanoDrop Technologies, Thermo Scientific, USA). All PCR was 
performed using 0.2 U of Dream Taq DNA polymerase (Fermentas, 
Thermo Fisher Scientific, USA) in a 20 ml reaction. The PCR 
mixture contained 1x Taq polymerase buffer, 0.5 pmol of forward 
and reverse primers (Table 1), 0.2 mM dNTPs, and 100 ng template 
DNA. For the molecular identification of the cyanobacteria, 16S 
rDNA oligonucleotide primers, CYA106F-CYA781R (Nubel et al., 
1997) and ITS-23S rDNA (Tillett et al., 2000) P322-P340, (Iteman et 
al., 2000) were used and synthesized by (Bioneer, Korea). PCR 
reactions were performed as previously described for each primer 
pair (Al-Tebrineh et al., 2011; Iteman et al., 2000; Jungblut et al., 
2006; Nubel et al., 1997). 
 
 
PCR amplification of HEP genes 
 
The HEP-F and HEP-R oligonucleotide primers targeting the 
aminotransferase (AMT) domain of the hepatotoxin synthetase 
mcyE and ndaF genes (Bioneer, Korea) were used for determining 
whether that toxicity gene is present or absent in the isolated 
bacteria (Amer  et al., 2009; Jungblut et al., 2006). The AMT 
primers HEP-F and HEP-R (Table 1) were used to amplify the 472 
bp PCR product. DNA isolated from EGY isolate and positive 
control DNA isolated from toxin producing Nostoc sp were used as 
template for PCR amplification using this primers. The initial 
temperature of 94
°
C for 2 min, followed by 35 cycles at 92
°
C for 50 
s, 52
°
C for 1 min, and 72
°
C for 1 min, with a final extension step at 
72
°
C for 10 min. 
 
 
Preparation of blue green algae (BGA) lysate 
 
Cultivated cells of EGY strain were collected by centrifugation at
 




Table 1. List of primers used for PCR and sequencing in this study. 
 
Primer ID Primer sequence 5'-3' Target Reference 
CYA106F CGGACGGGTGAGTAACGCGTGA 16S rDNA (Nubel et al., 1997) 
CYA781R GACTACTGGGGTATCTAATCCC(A/T)TT 16S rDNA (Nubel et al., 1997) 
P322F TGTACACACCGCCCGTC End of 16S rDNA (Iteman et al., 2000) 
P340R CTCTGTGTGCCTAGGTATCC 23S rDNA (Iteman et al., 2000) 
HEPF TTTGGGGTTAACTTTTTTGGGCATAGTC mcyE/ndaF (Jungblut et al., 2006) 




5000 rpm for 15 min at 4
°
C followed by lypholization. Lyophilized 
cells were broken down into powder using liquid nitrogen (10 times 
volume of the dried cells) the resulted powder were dissolved in 
normal saline with EDTA free protease inhibitor cocktail (Roche, 
USA) at 20 mg/ml, sterilized by filtration to be ready for testing. In 
order to find out relation between the cell density/suitable cultivation 
time and anti-HCV activity, BGA lysate was also prepared from 
cultivated EGY cells and collected at time intervals from 5 up to 60 
days.  Cell density and dry cell weight were determined and anti 
HCV activity was determined. 
 
 
Anti HCV activity 
 
During the last few years, a number of cell culture systems showed 
to have the ability to harbor and support reliable and efficient 
progression of this virus. Among several human hepatocyte cell 
lines analyzed, the hepatocellular carcinoma HepG2 cell line was 
found to be most susceptible to the HCV infection (El-Awady et al., 
2006). Also, human peripheral blood mononuclear cells (PBMC) 
showed the ability to harbor the replication of HCV in vitro and also 
HCV viral particles was reported to be harbored inside the PBMC of 
the HCV infected patients (el-Awady et al., 2005). 
On the other hand, monitoring of the HCV viremia pre- and post-
antiviral therapy through the detection of viral (+) and/or (-) RNA 
strands by the use of qualitative reverse transcription-polymerase 
chain reaction (RT-PCR) has become the most frequently-used, 
reliable and sensitive technique. Recently, it has been reported that 
the detection of the (-) strand HCV-RNA using the RT-PCR is a very 
important tool for understanding the life cycle of the HCV and 
provides a reliable marker for the diagnosis of HCV and monitoring 
the viral response to antiviral therapy (El-Awady et al., 1999). 
 
 
 Neutral red uptake assay to measure cytotoxicity on human 
cells 
 
Peripheral blood lymphocytes (PBMC) were separated from whole 
blood of healthy volunteer using gradient separation by Ficoll-
Paque™ Plus (MP Biomedicals, France), 10X10
4
 lymphocyte cells 
were seeded per well in 96 well plates and incubated in culture 
media (CM, RPMI1640 (Loza) media supplemented with 200 μM L-
glutamine (Lonza), 25 μM HEPES buffer; N- [2-hydroxyethyl] 
piperazine-N'-[2-ethanesulphonic acid] (lonza) and 10% Fetal 
bovine serum, FBS, Lonza) containing different concentrations of 
the BGA lysate for 24, 48, 72 and 96 h. The fraction of viable 
lymphocyte cells was measured by the Neutral Red assay 
(Guillermo Repetto, 2008). The neutral red assay is based on the 
initial protocol described by Borenfreund and Puerner (Borenfreund 
and Puerner, 1984) and determines the accumulation of the neutral 
red dye in the lysosomes of viable cells (Fotakis and Timbrell, 
2006). Following exposure of isolated PBMC to different 
concentrations of BGA lysate, cells were incubated for 3 h with 
neutral red dye (40 µg/ml) dissolved in culture media RPMI. Cells 
were then washed with Phosphate Buffered Saline (PBS) and the 
addition of 1 ml of elution medium (50% ethanol /1% glacial acetic 
acid /49% water) followed by gentle shaking for 10 min so that 
complete dissolution was achieved. Aliquots of the resulting 
solutions were transferred to 96-well plates and absorbance at 490 
nm was recorded using microtiter plate reader spectrophotometer 
(Biotek, USA). IC50 was estimated by plot x-y and fit the data with a 
straight line (linear regression) using IC50 was determined using 
Prism statistics software program. 
 
 
Detection of the effect of the BGA lysate on HCV cultivated in 
human cancer cell line 
 
Human cancer cell line, HepG2 cells, were washed twice in 
RPMI1640 (Loza) media supplemented with 200 μM L-glutamine 
(Lonza) and 25 μM HEPES buffer; N- [2-hydroxyethyl] piperazine-





in RPMI CM.  The cells were left to adhere on the 
polystyrene 6-well plates for 24 h in 37˚C, 5% CO2, 95% humidity 
incubator.  After 24 h the cells were washed twice from debris and 
dead cells by using RPMI supplemented media. Cells were infected 
by incubation for 24 h with 4% HCV infected serum, followed by 
addition of culture media and depending on th value of the 
determined IC50, different concentrations of BGA (1, 10, 160, 1, 1.6 
µg/ml) were added. Positive (HCV infected cells) and negative 
control (uninfected cells) cultures were included. Cultures were 
incubated for 96 h in 37˚C, 5% CO2, 95% humidity. The tested BGA 
concentration is considered to be active when it is capable of 
inhibiting the viral replication inside the HCV-infected HepG2 cells, 
as evidenced by the disappearance of the viral RNA-amplified 




RNA extraction and RT-PCR of HCV RNA 
 
Total RNA was extracted from HCV-infected HepG2 cells using the 
method described by El-Awady et al. (El-Awady et al., 1999). 
Briefly, culture cells were collected in 200 µl of Solution D (4 M 
guanidinium isothiocyanate containing 25 mM sodium citrate, 0.5% 
sarcosyl, 0.1 M β- mercaptoethanol, 100 µl sodium acetate). The 
cell lysate was mixed with an equal volume of RNA phenol, 
chloroform and isoamyl alcohol mixture (pH 4, Fisher Scientific, 
USA), mixing vigorously by vortex, followed by centrifugation at 14 
K rpm for 10 min at 4°C. The aqueous layer was collected and 
mixed with an equal volume of isopropanol then incubated 
overnight at -20°C. RNA was collected by centrifugation at 14 K 
rpm for 30 min at 4°C followed by washing twice with 70% ethanol 
then suspended in RNase free water. Concentration and purity 
(260/280 nm ratio) was determined using UV spectrophotometer. 













Figure 1. Ligth microscope filed showing the obtained pure 






Figure 2. Scanning electron microscope for EGY by 




nested PCR detection system for the HCV RNA was performed in a 
50 µL volume single-step reaction using the Ready-To-Go RT-PCR 
beads (GE Healthcare, USA) followed the detailed protocol 
described by El Awady et al, 2002 (El Awady et al., 2002).  The 




Quanititative in-vitro anti-HCV screening 
 
Same BGA concentrations were examined for its anti HCV activity 
quantitatively using same culture system used for qualitative test 
and analytikjena HCV viral RNA extraction kit and Robogen HCV 
quantitative kit (Bometera, Germany) 






Isolation and microscopic examination 
 
The unialgal culture was obtained after primary and 
secondary screening on BG12 media plates and broth. 
The pure isolate EGY was examined for its morphological 
characterization under the light microscope (Figure 1) 
going to scanning electron microscope (SEM) (Figure 2). 
The figures showed that the isolated cyanobacterium was 
filamentous with the presence of hetercysts and akinetes 
that may belongs to group Nostocales. 
 
 
Molecular identification of EGY by amplification of 
16S rDNA gene 
 
The DNA was extracted from EGY by the method 
described by Tillett and Neilan 2000. The cyanobacterial 
universal primers CYA106F-CYA781R were used for the 
identification of the pure isolate EGY. The obtained 16S 
rDNA PCR product was amplified and partially 
sequenced and analyzed by Bioneer Company, Korea. 
The resulting phylogenetic reconstructions were shown in 
Figure 3 on the basis of neighbor-joining analysis. The 
data showed in Figure 3 ensure the results of the 
microscopic examination that the EGY belongs to family 
Nostocales. It showed highest similarity to 91% to Nostoc 
sp. PCC 9426. The obtained sequence was added to the 
GenBank data base under the accession number 
JQ220408.1 and designated as Nostoc sp. EGY. As the 
similarity obtained from the partial sequence of the 16S 
rDNA is slightly low the 16S-ITS-23S rDNA which was 
amplified to confirm the 16S rDNA results and to confirm 
the genus of the isolated bacteria. As shown in Figure 4, 
the sequence of the PCR product of 16S-23S ITS 
showed 98% similarity with Nostoc sp. NR1 (2012) 16S-
23S ribosomal RNA intergenic spacer from the GenBank. 
The obtained sequence was added to the data base 
under accession number JQ220407.1 and designated as 
Nostoc sp. EGY 16S ribosomal RNA gene and 16S-23S 
ribosomal RNA intergenic spacer, partial sequence.  
 
 
Amplification of HEP genes   
 
The identification of the hepatotoxin cyanobacteria is 
performed by amplification of AMT domain of hepatotoxin 
synthetase mcyE gene (Amer  et al., 2009; Jungblut et 
al., 2006). The amplification of HEP genes of Nostoc sp. 
EGY versus the positive control (microcystine producing 
strain) was visualized on 2% agarose gel. The data 
showed the absence of 472 bp band for Nostoc sp. EGY 
and presence of the same band is the positive control. 
Therefore, Nostoc sp. EGY can be used for farther 
investigations.  
 




















































Figure 3. Neighbor-joining tree based on 16S rDNA sequences (CYA primers) of the EGY. 
Evolutionary distances were calculated using the Kimura 2 model using MEGA5 software. The 
numerals show the results of the bootstrap analysis values from 1000 replicates (only bootstrap 






































Figure 4. Neighbor-joining tree based on ITS sequences (P322-P340 primers) of Iso-1 
and Iso-2 isolates isolated from Nile River. Evolutionary distances were calculated 
using the Kimura 2 model using MEGA5 software. The numerals show the results of 
the bootstrap analysis values from 1000 replicates. The sequence in bold was 




























IC50 = 43mg/ml 
 
 






















Table 2. Cyanobacteria growth curve and anti-HCV 
activity. 
 
















Anti HCV activity 
 
As indicated in Figure 5 the IC50 of BGA lysate is 43 
mg/ml. Safe concentration ≤ 1/100 the IC50 (0.4 mg/ml) 
was examined for the anti HCV activity. Safe 
concentration was able to prevent HCV replication (data 
not showed). Much Lower concentrations were tested for 
anti-HCV activity (1, 10, 160, 1, 1.6 µg/ml) all of selected 
concentrations were able to prevent HCV replication in 
the in vitro  HCV culture  system  (Figure 6).  Where, viral  




Table 3. Quantitative RT-PCR of anti HCV activity of the 
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Figure 7. Cultivation of the organism in its selected suitable 




load was almost equal to zero at concentrations 10 160, 
1, 1.6 µg/ml while 1 ng and 0.5 ng/ml showed very low 
viral load as compared to the positive control but the 
percent inhibition of viral replication was almost 100% at 
all used BGA concentrations (Table 3).  
As presented in Table 2 and Figure 7 anti HCV activity 
was influenced by cultivation time where anti-HCV activity 
was detected with lysate of 10 and 25 days of culture 
while the lysate of the rest of cultivation time intervals 
have no anti HCV activity. This data indicated that 
cultivation time is very crucial for BGA activity against 





According to the taxonomic identification of Komárek and 
Anagnostidis (Komárek, 2005) the phenotype of the 
isolated cyanobacteria was characterized as a genus 
belongs to group of Nostocales as the filaments showed 
the presence of heterocysts and akinetes. The analysis of 
16S rDNA and 23S-ITS rDNA together with the 
microscopic examination revealed that the isolated 
cyanobacterium was designated as Nostoc sp. EGY. The 
association of N2-fixing cyanobacteria is commonly 
known in the rice filed due to the lack of nitrogen. Nostoc 
as one of the N2-fixing cyanobacteria has been isolated 
and characterized by many authors from the roots of the 
rice plants (Nilsson et al., 2002). The absence of 
amplicon from the PCR amplification of aminotransferase 
(AMT) domain  of  the hepatotoxin synthetase  mcyE and 
 




ndaF genes by using HEP primers revealed that the 
isolated strain was not a hepatoxic strain. Whereas, 
these primers were used before for the characterization 
of the genes responsible for hepatotoxin biosynthesis 
(Amer et al., 2009; Jungblut et al., 2006).  
Recently, Hashtroudi et al (Hashtroudi et al., 2013) was 
able to isolate four major carotenoids from Nostoc sp that 
can be used for nutrition or production of supportive 
medicine. Also, edible Nostoc sp was proven to have 
component that can act as anti herpes simplex virus 
(Kanekiyo et al., 2007). Other Nostoc sp was showed to 
have hypocholesterolemic efficacy (Rasmussen et al., 
2009). Several reports have indicated the ability of small 
protein, cyanivirin N, of cyanobacteria Nostoc sp act as 
potent antivirus to HIV, Ebola, Influanza, and HCV 
(Barrientos et al., 2003; Boyd et al., 1997; Buffa et al., 
2009; Dey et al., 2000; Helle et al., 2006; O'Keefe et al., 
2003; Tsai et al., 2004).  Also, cyanovirin-N has been 
recently evaluated for treatment of HIV infection (Buffa et 
al., 2009; Zappe et al., 2008). Accordingly, the new 
identified isolate presented in this study Nostoc sp. EGY 
may have the same anti viral component. However, more 
detailed study is required for the identification of detailed 
effect of the new isolated strain lysate on HCV 
replication. The absence of hepatotoxin synthetase mcyE 
gene indicate acceptable safety of the isolated Nostoc sp. 
EGY which increase the possibility of using this isolated 
strain for designing an effective anti HCV medication.  
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